Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,790,363,732
+$94,366,283 QoQ
Shares Held
7,114,782
-8.8% QoQ
Ownership
0.403%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#33
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 94%
None 6%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $27,851,957,097 across 16 Drug Manufacturers - General names. ABBV ranks #7 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
16,320,446 | $5,909,959,895 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
39,819,151 | $5,030,751,525 | |
| 3 | LLY |
ELI LILLY & Co
|
3,694,152 | $4,430,877,092 | |
| 4 | JNJ |
Johnson & Johnson
|
15,674,093 | $3,980,749,389 | |
| 5 | MRK |
Merck & Co., Inc.
|
18,611,171 | $2,391,535,466 | |
| 6 | AZN |
Astrazeneca PLC
|
10,177,013 | $1,929,765,193 | |
| 7 | ABBV |
AbbVie Inc.
This page
|
7,114,782 | $1,790,363,732 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
16,033,480 | $923,849,108 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,790,363,732 | 7,114,782 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,695,997,449 | 7,798,048 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $1,852,478,094 | 8,107,480 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $1,722,384,831 | 7,438,822 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,298,711,664 | 6,996,615 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,753,064,096 | 8,367,049 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,265,257,041 | 7,120,186 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,532,125,266 | 7,758,382 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $974,010,272 | 5,678,698 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $968,445,304 | 5,318,206 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $816,430,764 | 5,268,315 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $943,855,064 | 6,332,048 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $892,523,053 | 6,624,531 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,290,141,258 | 8,095,258 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,454,200,868 | 8,998,211 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,137,368,541 | 8,474,544 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,196,942,326 | 7,814,980 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $999,684,053 | 6,166,702 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $795,031,424 | 5,871,724 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $553,613,858 | 5,132,232 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $544,933,953 | 4,837,837 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $537,674,940 | 4,968,351 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $444,797,752 | 4,151,169 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $349,110,081 | 3,985,730 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $339,058,242 | 3,453,435 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $171,688,671 | 2,253,428 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||